��������

Ali Mohamed joined Immatics in May 2016 and is responsible for all aspects of process development and GMP manufacturing of Immatics T-cell products.

Previously, Ali held CMC related roles in multiple CMOs and clinical stage biotechnology companies in the field of cell & gene therapies. His previous role was at Hitachi PCT in Allendale NJ as senior director of GMP manufacturing and manufacturing development. Prior to joining Hitachi PCT, Ali held the role of director of GMP manufacturing and process development at AlloCure, a clinical stage company developing cell-based therapies for acute kidney injury. Prior to that Ali was the senior management of process development at Lonza in Walkersville, MD helping various cell therapy companies with developing cell-based products for various diseases. Ali also held scientist/senior scientist positions at a few small biotechnology companies including Neurologic (Rockville, MD), Psychiatric Genomics (Gaithersburg, MD), and Osiris Therapeutics (Baltimore, MD).

Ali Mohamed holds a PhD in Biomedical Sciences with concentration of Pharmacology from the University of Toledo (formerly Medical College of Ohio), postdoctoral training from the Georgetown Institute of Cognitive and Computation Sciences (GICCS) in Washington, DC, and Bachelor in Pharmaceutical Sciences from the Cairo University in Egypt.